Transaction · 0001437749-26-031924

Vu Quan Anh

Vu Quan Anh, CFO, reported a transaction classified as withholding at Monopar Therapeutics involving 180.000000 shares for an estimated $14340.60. Reported holdings after the transaction were 2655.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

withholdingSEC transaction code FCFO
MNPRMonopar Therapeutics
Filing timeOct 02
Trade dateSep 30, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position tradedUnavailableCalculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$77.97
Pre-filing
1mo ago +43.6%1w ago +14.6%1d ago +2.6%
Returns since
7d30d90d180d1y

MNPR price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
MNPR since 2026-10-02Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
withholding
Code F
Identifier
0001437749-26-031924
Common Stock
Transaction date
Sep 30, 2026
Filed Oct 02, 2026, 10:14 PM · 2d delay
Shares
180 sh
$79.67 per share
Estimated value
-$14.3k
Computed from shares × price
Holdings after
2.65k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership
-12score
Filing-only score

-12

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Financial Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Represents shares acquired on vesting and settlement of restricted stock units.

  2. F2

    Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units.

  3. F3

    On December 2, 2025, the reporting person was granted 9,826 restricted stock units, vesting 6/48ths (1,228) on June 30, 2026, and 3/48ths (614 shares) every 3 months thereafter until the RSU is fully…

Original filing · 0001437749-26-031924
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

MNPR